HEALWELL receives consent from the Overseas Investment Office of New Zealand (the “OIO”) for HEALWELL to acquire all of the shares (the “Orion Shares”) of Orion Health Holdings Limited (“Orion… Read More
EMBLAVEOTM is the first and only monobactam/β-lactamase inhibitor combination antibiotic therapy approved by the U.S. FDA to treat complicated intra-abdominal infections, including those caused by Gram-negative bacteria Gram-negative bacterial infections represent… Read More
Funding will help adMare BioInnovations create a 30,000 square foot innovation centre in Vancouver to propel local biotech research and development VANCOUVER, BC – British Columbia is home to a… Read More
TORONTO, ON – Suset Silva, Vice President of Culture, Communications, and Engagement at LifeLabs, has been ranked #2 in the Top 50 Women Leaders in Healthcare Technology by the Healthcare Technology… Read More
VANCOUVER, BC – Rakovina Therapeutics Inc. (TSX-V: RKV) (FSE: 7JO), a biopharmaceutical company advancing cancer therapies based on DNA-damage response technologies, announces continued advancement of its AI-driven drug discovery program…. Read More
